ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Human Sperm Binding to Transgenic Mouse Eggs

This study is ongoing, but not recruiting participants.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00340587
  Purpose

At fertilization, the binding of sperm to the zona pellucida induces the acrosome reaction releasing lytic enzymes that facilitate the passage of the sperm through the zona. The sperm then fuses with the egg's plasm membrane and enters the egg's cytoplasm. The zona pellucida, an extracellular matrix composed of three glycoproteins (ZP1, ZP2, ZP3), mediates the species-specific binding of sperm to egg. Although homologous proteins are present in mouse and humans, human sperm will not bind to the mouse zona pellucida and when the zona pellucida is experimentally removed, human sperm will not bind or fuse to the mouse egg's plasm membrane. We have created transgenic mouse lines that express one or more human zona proteins. We wish to determine if human sperm will bind to these chimeric zonae and if this binding will induce the human sperm acrosome reaction. Sperm and devitalized eggs will be collected by collaborating institution(s) under protocols and consent forms approved by that institution's IRB. Only procedures already being performed on subjects for diagnostic or treatment purposes will be used.


Condition
Fertilization

MedlinePlus related topics:   Shingles   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Human Sperm Binding to Transgenic Mouse Eggs

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   40
Study Start Date:   May 1997

Detailed Description:

At fertilization, the binding of sperm to the zona pellucida induces the acrosome reaction releasing lytic enzymes that facilitate the passage of the sperm through the zona. The sperm then fuses with the egg's plasm membrane and enters the egg's cytoplasm. The zona pellucida, an extracellular matrix composed of three or four glycoproteins, mediates the species-specific binding of sperm to egg. Although homologous proteins are present in mouse and humans, human sperm will not bind to the mouse zona pellucida and when the zona pellucida is experimentally removed, human sperm will not bind or fuse to the mouse egg's plasm membrane. We have created transgenic mouse lines that express one or more human zona proteins. We wish to determine if human sperm will bind to these chimeric zonae and if this binding will induce the human sperm acrosome reaction. Sperm and devitalized eggs will be collected by collaborating institution(s) under protocols and consent forms approved by that institution's IRB. Alternatively, anonymous fertile human sperm will be obtained from a commercial sperm bank using a donor consent agreement. Only procedures already being performed on subjects for diagnostic or treatment purposes will be used.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • INCLUSION CRITERIA:

Without regard to ethnic/race background, all subjects will be men and women over the age of 18 who are neither mentally retarded nor disabled.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00340587

Locations
United States, Maryland
Suburban Hospital    
      Bethesda, Maryland, United States, 20814

Sponsors and Collaborators
  More Information

Study ID Numbers:   999997039, OH97-DK-N039
First Received:   June 19, 2006
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00340587
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Zona Pellucida  
Human Eggs  
ZP1, ZP2, ZP3  
Fertilization  

Study placed in the following topic categories:
Herpes Zoster
Spastic paraplegia epilepsy mental retardation

ClinicalTrials.gov processed this record on September 04, 2008




Links to all studies - primarily for crawlers